These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1876779)
1. Analysis of the crossover design in the presence of residual effects. Lehmacher W Stat Med; 1991 Jun; 10(6):891-9. PubMed ID: 1876779 [TBL] [Abstract][Full Text] [Related]
2. Using the maximum test statistic in the two-period crossover clinical trial. Willan AR Biometrics; 1988 Mar; 44(1):211-8. PubMed ID: 3358989 [TBL] [Abstract][Full Text] [Related]
3. The crossover experiment for clinical trials. Brown BW Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374 [TBL] [Abstract][Full Text] [Related]
4. A critique of recent research on the two-treatment crossover design. Fleiss JL Control Clin Trials; 1989 Sep; 10(3):237-43. PubMed ID: 2676339 [TBL] [Abstract][Full Text] [Related]
5. A Bayesian analysis of the two-period crossover design for clinical trials. Grieve AP Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262 [TBL] [Abstract][Full Text] [Related]
6. A simple method for the estimation of interaction bias in crossover studies. Cleophas TJ J Clin Pharmacol; 1990 Nov; 30(11):1036-40. PubMed ID: 2243151 [TBL] [Abstract][Full Text] [Related]
7. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Freeman PR Stat Med; 1989 Dec; 8(12):1421-32. PubMed ID: 2616932 [TBL] [Abstract][Full Text] [Related]
8. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models. Gondaliya J; Divecha J Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221 [TBL] [Abstract][Full Text] [Related]
9. Optimal crossover designs in the presence of carryover effects. Laska E; Meisner M; Kushner HB Biometrics; 1983 Dec; 39(4):1087-91. PubMed ID: 6671121 [TBL] [Abstract][Full Text] [Related]
10. Crossover trials with a binary response: a powerful method despite the carryover effect. Cleophas TJ; van Lier HJ J Clin Pharmacol; 1996 Mar; 36(3):198-202. PubMed ID: 8690812 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis combining parallel and crossover trials using generalised estimating equation method. Curtin F Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280 [TBL] [Abstract][Full Text] [Related]
12. Carryover negligibility and relevance in bioequivalence studies. OcaƱa J; Sanchez O MP; Carrasco JL Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204 [TBL] [Abstract][Full Text] [Related]
13. A note on misspecification in general linear models with correlated errors for the analysis of crossover clinical trials. Wang W; Cong N; Chen T; Zhang H; Zhang B PLoS One; 2019; 14(3):e0213436. PubMed ID: 30870443 [TBL] [Abstract][Full Text] [Related]
15. The two-period crossover design in medical research. Woods JR; Williams JG; Tavel M Ann Intern Med; 1989 Apr; 110(7):560-6. PubMed ID: 2923388 [TBL] [Abstract][Full Text] [Related]